JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D
JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D
Not yet recruiting · NCT07845955 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JAK1 Inhibitor Ivarmacitinib for Improving Pancreatic Islet Function in T1D | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Not yet recruiting | Phase 2 | 2026-09-29 | NCT07845955 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Huijie Zhang | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongshan Hospital, Fudan University | Shanghai | China | 86 |